You have 9 free searches left this month | for more free features.

Liposomal doxorubicin

Showing 1 - 25 of 1,970

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance

Not yet recruiting
  • Metastatic Leiomyosarcoma
  • +5 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Feb 2, 2023

Relapsed Sarcomas Trial in Cleveland (Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil))

Not yet recruiting
  • Relapsed Sarcomas
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Apr 18, 2022

Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)

Not yet recruiting
  • Kaposi Sarcoma
  • HIV-1-infection
  • (no location specified)
Jul 20, 2022

Breast Cancer Trial in Paris, Barcelone, Madrid (Trastuzumab and non-pegylated liposomal doxorubicin)

Completed
  • Breast Cancer
  • Trastuzumab and non-pegylated liposomal doxorubicin
  • Paris, France
  • +3 more
Feb 8, 2022

Advanced Malignant Tumors Trial in Shanghai (doxorubicin HCl liposome injection)

Recruiting
  • Advanced Malignant Tumors
  • doxorubicin hydrochloride liposome injection
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 28, 2022

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)

Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
Nov 15, 2021

Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients Trial in Guangzhou (Blood sampling)

Recruiting
  • Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
  • Blood sampling
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Dec 21, 2021

Recurrent Ovarian Cancer Trial (DOXIL, Withaferin A, Ashwagandha)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • (no location specified)
Jan 27, 2023

Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, ALX148, Doxorubicin)

Not yet recruiting
  • Ovarian Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 19, 2022

Breast Cancer Trial in Shanghai (sintilimab, bevacizumab biosimilar, pegylated liposomal doxorubicin)

Recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 22, 2022

Solid Tumors Trial in Milano, Bellinzona, Chur (AZD2281, liposomal doxorubicin)

Active, not recruiting
  • Solid Tumors
  • Milano, Italy
  • +2 more
Nov 17, 2021

Breast Cancer Trial in Guandong (pegylated liposomal doxorubicin (PLD), cyclophosphamide (C), trastuzumab (H))

Recruiting
  • Breast Cancer
  • pegylated liposomal doxorubicin (PLD)
  • +5 more
  • Guandong, Guangdong, China
    Sunyat-sen Memorial Hospital
Feb 17, 2022

Ovarian Cancer Trial in Indianapolis, Madison (Doxil (Pegylated Liposomal Doxorubicin), BIBF 1120)

Terminated
  • Ovarian Cancer
  • Doxil (Pegylated Liposomal Doxorubicin)
  • BIBF 1120
  • Indianapolis, Indiana
  • +1 more
Feb 14, 2022

Breast Cancer Trial in Prague, Haifa, Candiolo (drug, radiation, device)

Withdrawn
  • Breast Cancer
  • ThermoDox (Thermally Sensitive Liposomal Doxorubicin)
  • +2 more
  • Prague, Czechia
  • +2 more
Mar 29, 2022

Advanced Solid Tumors Trial in Switzerland (TLD-1, Caelyx)

Recruiting
  • Advanced Solid Tumors
  • Bellinzona, Switzerland
  • +3 more
Dec 24, 2021

Ovarian Cancer Trial in Villejuif (Pembrolizumab, Bevacizumab, pegylated liposomal doxorubicin (PLD))

Active, not recruiting
  • Ovarian Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 21, 2021

Desmoid Tumor Trial in GuangZhou (Liposome doxorubicin, Saline Solution)

Recruiting
  • Desmoid Tumor
  • Liposome doxorubicin
  • Saline Solution
  • GuangZhou, Guangdong, China
    Sun Yat-sen University cancer center
Sep 29, 2022

Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,

Recruiting
  • Pediatric Cancer
  • +9 more
  • Magnetic resonance high intensity focused ultrasound
  • Lyso-thermosensitive liposomal doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
Dec 10, 2021

Lymphoma Trial in Shanghai (liposomal doxorubicin)

Recruiting
  • Lymphoma
  • liposomal doxorubicin
  • Shanghai, Shanghai, China
    Ruijin Hospital
Mar 13, 2021

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • Pegylated Liposomal Doxorubicin + SL-172154
  • Mirvetuximab + SL-172154
  • (no location specified)
Jul 29, 2022

Ovarian Cancer Trial (EC145, Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®), )

Terminated
  • Ovarian Cancer
  • (no location specified)
Sep 24, 2021

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in New

Suspended
  • Estrogen Receptor-negative Breast Cancer
  • +8 more
  • pegylated liposomal doxorubicin hydrochloride
  • +6 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021